Insiders · Profile

Mazumdar Claire

Chief Executive Officer at Bicara Therapeutics. Filing since 13 Oct 2025. CIK 0002034671

Company

Date

Role

Action

Shares

Amount

Of holding

BCAX Bicara Therapeutics Inc.

10 Aug 2026

Chief Executive Officer

Sold on a plan

10,000

$279.75K

2.7%

BCAX Bicara Therapeutics Inc.

10 Jul 2026

Chief Executive Officer

Sold on a plan

10,000

$284.20K

2.7%

BCAX Bicara Therapeutics Inc.

18 May 2026

Chief Executive Officer

Sold on a plan

15,000

$300.58K

4.0%

BCAX Bicara Therapeutics Inc.

20 Apr 2026

Chief Executive Officer

Sold on a plan

15,000

$354.15K

4.0%

BCAX Bicara Therapeutics Inc.

20 Mar 2026

Chief Executive Officer

Sold on a plan

1,596

$30.25K

0.5%

BCAX Bicara Therapeutics Inc.

19 Mar 2026

Chief Executive Officer

Sold on a plan

6,905

$129.70K

2.0%

BCAX Bicara Therapeutics Inc.

18 Mar 2026

Chief Executive Officer

Sold on a plan

6,499

$122.41K

1.9%

BCAX Bicara Therapeutics Inc.

9 Mar 2026

Chief Executive Officer

Sold on a plan

36,766

$704.66K

9.8%

BCAX Bicara Therapeutics Inc.

6 Mar 2026

Chief Executive Officer

Sold on a plan

3,817

$71.57K

1.1%

BCAX Bicara Therapeutics Inc.

5 Mar 2026

Chief Executive Officer

Sold on a plan

1,786

$33.46K

0.5%

BCAX Bicara Therapeutics Inc.

4 Mar 2026

Chief Executive Officer

Sold on a plan

2,631

$49.29K

0.8%

BCAX Bicara Therapeutics Inc.

24 Nov 2025

Chief Executive Officer

Sold on a plan

41,163

$776.43K

11.7%

BCAX Bicara Therapeutics Inc.

16 Oct 2025

Chief Executive Officer

Sold on a plan

24,103

$453.76K

7.2%

BCAX Bicara Therapeutics Inc.

15 Oct 2025

Chief Executive Officer

Sold on a plan

13,289

$250.39K

4.1%

BCAX Bicara Therapeutics Inc.

13 Oct 2025

Chief Executive Officer

Sold on a plan

11,445

$216.55K

3.6%

15 decisions on file.